BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 6171376)

  • 1. [Sodium etidronate (EHDP) and osteoporosis].
    Nuti R; Righi G; Turchetti V; Vattimo A
    Clin Ter; 1981 Oct; 99(1):33-42. PubMed ID: 6171376
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of Paget's disease of bone with ethane-1 hydroxy-1, 1 diphosphonate at low dosage (author's transl)].
    Alexandre C; Chapuy MC; Bressot C; Vignon E; Arlot M; Mathieu L; Edouard C; Johnston CC; Meunier PJ
    Nouv Presse Med; 1980 Nov; 9(45):3429-33. PubMed ID: 6777752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Behavior of urinary excretion of cyclic AMP in post-menopausal osteoporosis during therapy with salmon calcitonin].
    Nuti R; Galli M; Righi GA; Turchetti V; Campagna MS; Franci B
    Minerva Med; 1982 May; 73(19):1283-9. PubMed ID: 6281691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Etidronate disodium in postmenopausal osteoporosis.
    Heaney RP; Saville PD
    Clin Pharmacol Ther; 1976 Nov; 20(5):593-604. PubMed ID: 824086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neoplastic hypercalcemia: physiologic response to intravenous etidronate disodium.
    Jacobs TP; Gordon AC; Silverberg SJ; Shane E; Reich L; Clemens TL; Gundberg CM
    Am J Med; 1987 Feb; 82(2A):42-50. PubMed ID: 3030098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic effects of diphosphonate in primary hyperparathyroidism.
    Kaplan RA; Geho WB; Poindexter C; Haussler M; Dietz GW; Pak CY
    J Clin Pharmacol; 1977 Jul; 17(7):410-9. PubMed ID: 195983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of the effect of risedronate and etidronate on lumbar bone mineral density in Japanese patients with osteoporosis: a randomized controlled trial.
    Fukunaga M; Kushida K; Kishimoto H; Shiraki M; Taketani Y; Minaguchi H; Inoue T; Morita R; Morii H; Yamamoto K; Ohashi Y; Orimo H;
    Osteoporos Int; 2002 Dec; 13(12):971-9. PubMed ID: 12459940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of osteoporosis with calcium infusions.
    Pak CY; Bartter FC
    Semin Drug Treat; 1972; 2(1):39-46. PubMed ID: 5048563
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of NaCl on calcium balance, parathyroid function and hydroxyproline excretion in prednisolone-treated rats consuming low calcium diet.
    Goulding A; McIntosh J
    J Nutr; 1986 Jun; 116(6):1037-44. PubMed ID: 3014091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Some effects of ethinyl oestradiol on calcium and phosphorus metabolism in osteoporosis.
    Young MM; Jasani C; Smith DA; Nordin BE
    Clin Sci; 1968 Jun; 34(3):411-7. PubMed ID: 5666871
    [No Abstract]   [Full Text] [Related]  

  • 11. [Laboratory tests and bone biopsy in the diagnosis and treatment of osteoporosis].
    Burckhardt P
    Rev Med Suisse Romande; 1982 Jun; 102(6):599-605. PubMed ID: 7134717
    [No Abstract]   [Full Text] [Related]  

  • 12. An evaluation of several biochemical markers for bone formation and resorption in a protocol utilizing cyclical parathyroid hormone and calcitonin therapy for osteoporosis.
    Hodsman AB; Fraher LJ; Ostbye T; Adachi JD; Steer BM
    J Clin Invest; 1993 Mar; 91(3):1138-48. PubMed ID: 8450043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 36 month intermittent cyclical etidronate treatment in patients with established corticosteroid induced osteoporosis.
    Sebaldt RJ; Ioannidis G; Adachi JD; Bensen WG; Bianchi F; Cividino A; Gordon M; Kaminska E; Scocchia T; Petrie A; Stephenson GF; Goldsmith CH
    J Rheumatol; 1999 Jul; 26(7):1545-9. PubMed ID: 10405943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of osteoporosis with calcium infusions.
    Lifschitz MD; Pak CY; Henneman D; Jowsey J; Pilch Y; Bartter FC
    Trans Assoc Am Physicians; 1970; 83():254-66. PubMed ID: 5505393
    [No Abstract]   [Full Text] [Related]  

  • 15. [Massive oral calcium therapy in the treatment of osteoporosis].
    Demartin F; Figna P
    Minerva Ortop; 1966 Jun; 17(6):345-50. PubMed ID: 4164344
    [No Abstract]   [Full Text] [Related]  

  • 16. [Metabolic effects of calcitonin in man].
    Caniggia A; Gennari C
    Minerva Med; 1973; 64(43):2249-58. PubMed ID: 4727514
    [No Abstract]   [Full Text] [Related]  

  • 17. Critical drug appraisal: etidronate intermittent cyclic therapy for postmenopausal osteoporosis.
    Miller PD
    Br J Clin Pract; 1996; 50(1):23-31. PubMed ID: 8729598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of propranolol and indomethacin upon urinary hydroxyproline in hyperthyroid patients (author's transl)].
    Beylot M; Vincent M; Benzoni D; Bodson A; Riou JP; Mornex R
    Nouv Presse Med; 1982 Mar; 11(13):989-91. PubMed ID: 7070987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of intermittent cyclical etidronate therapy on corticosteroid induced osteoporosis in Japanese patients with connective tissue disease: 3 year followup.
    Sato S; Ohosone Y; Suwa A; Yasuoka H; Nojima T; Fujii T; Kuwana M; Nakamura K; Mimori T; Hirakata M
    J Rheumatol; 2003 Dec; 30(12):2673-9. PubMed ID: 14719212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The option of etidronate in the treatment of osteoporosis].
    Palacios S
    An Med Interna; 1993 Aug; 10(8):367-8. PubMed ID: 8218779
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.